MarketCap
Facebook
X
Telegram
Sanara MedTech Balance Sheet 2025-2009 | SMTI
Brief overview of Sanara MedTech 's balance sheet strength
The review uses the five latest available annual reports between 2021 and 2025.
The asset base grew from $36.4 million to $72.9 million, or +100.4%. Average annual growth of roughly 19% was strong.
Liabilities grew faster than assets: +973.2% versus +100.4%. A substantial part of expansion was externally funded.
The equity ratio is 8.1%, compared with 84.2% before. Low autonomy increases reliance on liabilities.
Each unit of equity supports 5.01x of net debt. This elevated load requires dependable cash generation.
The cash share moved from 51.2% to 22.7%. A higher figure generally provides more room in an adverse scenario.
The accumulated result is -$75.3 million and remains below zero. The number alone does not explain whether losses, dividends or repurchases were the main cause.
Conclusion
Taken together, Sanara MedTech 's balance sheet indicators point to elevated risk. Asset growth does not offset weak funding sources.
Annual Balance Sheet Sanara MedTech
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
29.7 M | 15.2 M | 4.33 M | -8.14 M | -18.2 M | 26 K | -4.51 M | 768 K | 737 K | 785 K | 1.64 M | 1.08 M | 1.54 M | 2.37 M | 1.36 M | 385 K | - |
Long Term Debt |
46 M | 30.7 M | 9.11 M | 505 K | 222 K | - | 1.5 M | 1.5 M | - | 1.2 M | 1.2 M | - | - | 189 K | 810 K | 435 K | - |
Long Term Debt Current |
353 K | 359 K | 361 K | 314 K | 203 K | 126 K | 118 K | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
48.4 M | 33.9 M | 15.5 M | 6.51 M | 222 K | 446 K | 2.08 M | 1.53 M | - | 1.2 M | 1.2 M | 8.63 K | - | 189 K | 810 K | 435 K | - |
Total Current Liabilities |
18.6 M | 15.3 M | 13.8 M | 12.8 M | 6.02 M | 3.54 M | 2.64 M | 404 K | 2.12 M | 1.39 M | 1.46 M | 2.32 M | 3.45 M | 5.01 M | 6.88 M | 5.79 M | - |
Total Liabilities |
67 M | 49.2 M | 29.3 M | 19.3 M | 6.24 M | 3.99 M | 4.72 M | 1.93 M | 2.12 M | 2.59 M | 2.66 M | 2.32 M | 3.45 M | 5.2 M | 7.69 M | 6.23 M | - |
Retained Earnings |
-75.3 M | -37.8 M | -28 M | -23.4 M | -15.2 M | -7.03 M | -2.68 M | -47.5 M | -46.9 M | -47.2 M | -46.8 M | -45.4 M | -43.2 M | -39 M | -37.2 M | -24.4 M | - |
Total Assets |
72.9 M | 88.1 M | 73.9 M | 61 M | 36.4 M | 9.83 M | 11.1 M | 3.04 M | 2.22 M | 2.17 M | 1.39 M | 1.5 M | 977 K | 1.39 M | 3.83 M | 6.78 M | - |
Cash and Cash Equivalents |
16.6 M | 15.9 M | 5.15 M | 8.96 M | 18.7 M | 455 K | 6.61 M | 176 K | 463 K | 833 K | 182 K | 523 K | 44.6 K | 45.9 K | 3.61 K | 50.8 K | -4.36 K |
Book Value |
5.93 M | 38.9 M | 44.6 M | 41.7 M | 30.2 M | 5.84 M | 6.39 M | 1.11 M | 103 K | -423 K | -1.27 M | -825 K | -2.47 M | -3.81 M | -3.86 M | 558 K | - |
Total Shareholders Equity |
5.94 M | 39.4 M | 44.8 M | 41.8 M | 30.6 M | 6.15 M | 6.61 M | 1.11 M | 103 K | -423 K | -1.27 M | -825 K | -2.47 M | -3.81 M | -3.86 M | 558 K | 2.64 M |
All numbers in USD currency
Quarterly Balance Sheet Sanara MedTech
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
1.87 M | 46.2 M | 1.24 M | 45.1 M | 44.2 M | 43.4 M | 30.7 M | 30.1 M | 14.4 M | 8.77 M | 9.11 M | 9.46 M | 1.78 M | 1.86 M | 505 K | 568 K | 151 K | 187 K | 222 K | 257 K | 291 K | 324 K | 356 K | 468 K | 393 K | 356 K | - | 481 K | - | 481 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 103 K | 143 K | 174 K | 189 K | 189 K | 189 K | 189 K | 535 K | 535 K | 535 K | 535 K |
Total Non Current Liabilities |
48.4 M | 48.6 M | 33.9 M | 47.6 M | 48.5 M | 46.4 M | 33.9 M | 34.8 M | 20.4 M | 15.2 M | 15.5 M | 18.1 M | 7.43 M | 7.89 M | 6.51 M | 7.62 M | 4.1 M | 187 K | 222 K | 347 K | 381 K | 414 K | 446 K | 446 K | 446 K | 446 K | 2.08 M | 2.08 M | 2.08 M | 2.08 M | - | 1.51 M | - | - | - | - | - | - | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 1.2 M | 8.63 K | 8.63 K | 8.63 K | 8.63 K | - | 103 K | 143 K | 174 K | 189 K | 288 K | 189 K | 189 K | 810 K | 810 K | 810 K | 810 K |
Total Liabilities |
67 M | 62.3 M | 49.2 M | 64.9 M | 63.4 M | 59.7 M | 49.2 M | 49.1 M | 32 M | 27.9 M | 29.3 M | 31.4 M | 17.3 M | 18.5 M | 19.3 M | 16.8 M | 11 M | 5.42 M | 6.24 M | 4.51 M | 4.13 M | 3.55 M | 3.99 M | 3.99 M | 3.99 M | 3.99 M | 4.72 M | 4.72 M | 4.72 M | 4.72 M | 1.12 M | 2.1 M | 1.12 M | 1.12 M | 2.12 M | 2.12 M | 2.12 M | 2.12 M | 2.59 M | 2.59 M | 2.59 M | 2.59 M | 2.66 M | 2.66 M | 2.66 M | 2.66 M | 2.32 M | 2.32 M | 2.32 M | 2.32 M | 3.45 M | 6.67 M | 5.45 M | 6.09 M | 5.2 M | 5.2 M | 5.2 M | 5.2 M | 7.69 M | 7.69 M | 7.69 M | 7.69 M |
Retained Earnings |
-75.3 M | -74.5 M | -37.8 M | -73.7 M | -43.3 M | -41.3 M | -37.8 M | -36.2 M | -33.4 M | -29.9 M | -28 M | -27.8 M | -26.7 M | -24.9 M | -23.4 M | -19.1 M | -21.7 M | -18.4 M | -15.2 M | -11.4 M | -9.39 M | -8.21 M | -7.03 M | -7.03 M | -7.03 M | -7.03 M | -2.68 M | -2.68 M | -2.68 M | -2.68 M | 138 K | -47 M | 138 K | 138 K | -46.9 M | -46.9 M | -46.9 M | -46.9 M | -47.2 M | -47.2 M | -47.2 M | -47.2 M | -46.8 M | -46.8 M | -46.8 M | -46.8 M | -45.4 M | -45.4 M | -45.4 M | -45.4 M | -43.2 M | -43.2 M | -43.2 M | -43.2 M | -39 M | -39 M | -39 M | -39 M | -37.2 M | -37.2 M | -37.2 M | -37.2 M |
Total Assets |
72.9 M | 69.3 M | 88.1 M | 71.1 M | 98.8 M | 96.4 M | 88.1 M | 88.5 M | 73.4 M | 70.9 M | 73.9 M | 73.9 M | 73.9 M | 60 M | 61 M | 61.5 M | 46.5 M | 33.9 M | 36.4 M | 37.9 M | 38.8 M | 39 M | 9.83 M | 9.83 M | 9.83 M | 9.83 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 1.71 M | 3.69 M | 1.71 M | 1.71 M | 2.22 M | 2.22 M | 2.22 M | 2.22 M | 2.17 M | 2.17 M | 2.17 M | 2.17 M | 1.39 M | 1.39 M | 1.39 M | 1.39 M | 1.5 M | 1.5 M | 1.5 M | 1.5 M | 977 K | 977 K | 977 K | 977 K | 1.39 M | 1.39 M | 1.39 M | 1.39 M | 3.83 M | 3.83 M | 3.83 M | 3.83 M |
Cash and Cash Equivalents |
16.6 M | 13.6 M | 15.9 M | 14.9 M | 17 M | 20.7 M | 15.9 M | 16.3 M | 6.15 M | 2.83 M | 5.15 M | 6.24 M | 6.06 M | 7.29 M | 8.96 M | 10.3 M | 12.7 M | 16.1 M | 18.7 M | 22.4 M | 24.4 M | 27.3 M | 455 K | 455 K | 455 K | 455 K | 6.61 M | 6.61 M | 6.61 M | 6.61 M | 176 K | 646 K | 176 K | 176 K | 463 K | 463 K | 463 K | 463 K | 833 K | 833 K | 833 K | 833 K | 182 K | 182 K | 182 K | 182 K | 523 K | 523 K | 523 K | 523 K | 44.6 K | 44.6 K | 44.6 K | 44.6 K | 45.9 K | 45.9 K | 45.9 K | 45.9 K | 3.61 K | 3.61 K | 3.61 K | 3.61 K |
Book Value |
5.93 M | 7.02 M | 38.9 M | 6.14 M | 35.4 M | 36.7 M | 38.9 M | 39.5 M | 41.4 M | 43 M | 44.6 M | 42.5 M | 56.6 M | 41.5 M | 41.7 M | 44.6 M | 35.5 M | 28.5 M | 30.2 M | 33.4 M | 34.7 M | 35.5 M | 5.84 M | 5.84 M | 5.84 M | 5.84 M | 6.39 M | 6.39 M | 6.39 M | 6.39 M | 587 K | 1.59 M | 587 K | 587 K | 103 K | 103 K | 103 K | 103 K | -423 K | -423 K | -423 K | -423 K | -1.27 M | -1.27 M | -1.27 M | -1.27 M | -825 K | -825 K | -825 K | -825 K | -2.47 M | -5.69 M | -4.48 M | -5.12 M | -3.81 M | -3.81 M | -3.81 M | -3.81 M | -3.86 M | -3.86 M | -3.86 M | -3.86 M |
Total Shareholders Equity |
38.9 M | 7.03 M | 44.6 M | 6.15 M | 35.4 M | 36.7 M | 39.4 M | 39.5 M | 41.4 M | 43 M | 44.8 M | 44.1 M | 41 M | 41.5 M | 41.8 M | 44.6 M | 39.5 M | 28.5 M | 30.6 M | 33.4 M | 34.7 M | 35.5 M | 6.15 M | 5.84 M | 5.84 M | 6.15 M | 6.39 M | 6.61 M | 6.61 M | 6.61 M | 587 K | 1.59 M | 587 K | 587 K | 103 K | 103 K | 103 K | 103 K | -423 K | -423 K | -423 K | -423 K | -1.27 M | -1.27 M | -1.27 M | -1.27 M | -825 K | -825 K | -825 K | -825 K | -2.47 M | -2.47 M | -2.47 M | -2.47 M | -3.81 M | -3.81 M | -3.81 M | -3.81 M | -3.86 M | -3.86 M | -3.86 M | -3.86 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Sanara MedTech , providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Russia
USA
China
Germany
Britain
